Aspirin underused in secondary prevention of cardiovascular disease
Aug 24, 2023
Estimates of use increased from 16.6% in low-income countries to 65.0% in high-income countries.
Extreme heat projected to cause more excess cardiovascular deaths by midcentury
Oct 30, 2023
In one scenario, elderly adults are projected to have a 3.5 times greater increase in deaths compared with nonelderly adults.
Acute cardiac event reported in 22.4 percent of seniors hospitalized with RSV
Apr 15, 2024
Risk for experiencing acute cardiac event higher for adults with underlying cardiovascular disease
Pencil-weight cardiac monitor and app minimize interference in daily life, developers say
By
Aaron Dorman
Sep 27, 2023
A company that produces heart monitor devices has released an app and a new wearable patch that is lighter and thinner than previous models.
High-intensity statins underused with atherosclerotic cardiovascular disease
Sep 19, 2023
The authors say that the findings show gaps between practice and guideline-based care.
Second major AI study from NY hospital to look at links between sleep apnea and heart disease
By
Aaron Dorman
Mar 11, 2024
A research project at Mount Sinai will look at how AI can evaluate the ability for CPAP devices to help with sleep apnea and heart disease.
Loneliness, but not social isolation, tied to CVD risk with diabetes
Jul 03, 2023
Loneliness was found to be a stronger predictor than lifestyle factors.
Depression tied to higher risk of CVD events in both men and women
Mar 15, 2024
Although significant associations are seen for both, the associations are more pronounced in women.
How your residents can take control of their health with wearable devices
By
David Smith
Mar 16, 2023
The importance of preventive care increases significantly with age, especially when it comes to conditions as serious and common as heart disease. Far too many other older adults have succumbed to cardiovascular...
Statins reduce CVD risk in adults aged 75 to 85 and 85 years and older
May 28, 2024
A risk reduction was seen for overall cardiovascular disease incidence for initiating statin therapy in both intention-to-treat and per-protocol analyses.